x
0
SCOTTRADE ACCOUNT IT'S TIME. It's time for an easier way to invest. Open a Scottrade Account
Apply Now

Mallinckrodt (MNK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Mallinckrodt's earnings

Delivery

Website notifications

Mobile App notifications

Add to/Remove from a Portfolio My Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
45.91 +1.46    +3.28%
25/04 - Closed. Currency in USD ( Disclaimer )
After Hours
45.91
0.00
0.00%
20:32:20 GMT - Real-time Data
Type: Equity
Market: United States
ISIN: IE00BBGT3753 
CUSIP: 00BBGT375
  • Volume: 1,329,036
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 44.54 - 46.05
Start Trading
Mallinckrodt 45.91 +1.46 +3.28%

MNK Overview

 
Information about the Mallinckrodt Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close44.45
Day's Range44.54 - 46.05
Revenue3.3B
Open44.89
52 wk Range41.57 - 85.83
EPS1.72
Volume1,329,036
Market Cap4.81B
Dividend (Yield)0 (N/A)
Average Vol. (3m)1,870,853
P/E Ratio26.72
Beta1.52
1-Year Change - 28.37%
Shares Outstanding104,694,686
Next Earnings DateMay 08, 2017

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Neutral Buy Buy Neutral Strong Sell
Technical Indicators Sell Strong Buy Strong Buy BUY Strong Sell
Summary Neutral Strong Buy Strong Buy Neutral Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Three Black Crows 15 Current
Three Inside Up 1D Current
Completed Patterns
Three Inside Up 30 1 Apr 25, 2017 03:00PM
Engulfing Bearish 30 3 Apr 25, 2017 02:00PM
Three Outside Down 15 6 Apr 25, 2017 02:15PM

Mallinckrodt News & Analysis

Mallinckrodt Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NYSE 45.91 0.00 0.00 1,329,036 +3.28% USD 25/04  
  Stuttgart 41.147 41.264 42.863 0 -0.50% EUR 06:11:00  
  Berlin 42.100 41.280 42.910 0 +0.33% EUR 09:02:00  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery

Website notifications

Mobile App notifications

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 144.53 144.90 143.87 +0.89 +0.62% 18.87M 25/04  
  DLF 188.45 196.85 179.75 -5.75 -2.96% 18.19M 09:48:00  
  Tesla 313.79 313.98 305.86 +5.76 +1.87% 6.74M 25/04  
  Adani Enterprises 117.90 151.55 117.20 -32.05 -21.37% 42.19M 09:48:00  
  Reliance Industries 1,419.00 1,440.05 1,402.60 -13.80 -0.96% 3.63M 09:48:00  
  BMW ST 87.700 88.050 87.575 -0.070 -0.08% 472.99K 09:53:21  
  Amazon.com 907.62 909.48 903.00 +0.21 +0.02% 3.38M 25/04  
  Alphabet 888.84 892.25 879.28 +9.91 +1.13% 2.04M 25/04  
  Boeing 183.51 183.85 182.53 +1.45 +0.80% 3.74M 25/04  
  Facebook 146.49 147.15 145.79 +1.02 +0.70% 17.77M 25/04  

Mallinckrodt Company Profile

IndustryMajor Drugs
SectorHealthcare
Employees

4500

Equity Type

ORD

Mallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and hemostasis products, and central nervous system drugs. Its segments include Specialty Brands and Specialty Generics. The Specialty Brands segment produces and markets branded pharmaceutical products and therapies. The Specialty Generics segment produces and markets specialty generic pharmaceuticals and active pharmaceutical ingredient (API) consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients. Its product portfolio includes Acthar, Inomax, Ofirmev, Therakos immunotherapy, Hemostasis products and StrataGraft.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $1000 Start Trading
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading

My Sentiments

Add your sentiment:
or
 
Members' Sentiments:
Bullish
50%
Bearish
50%

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Latest MNK Comments

Norm Norm
Norm Norm Apr 13, 2016 3:36PM GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Easy money Citron wrong on this one and I believe Left has potentially opened himself up to a lawsuit by MNK.
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Please wait a minute before you try to comment again.
 
 
 
Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Add Chart to Comment
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.